Recombinant malaria vaccine

A kind of composition and technology of malaria parasite, applied in the field of recombinant malaria vaccine and preparation thereof

A kind of composition and technology of malaria parasite, applied in the field of recombinant malaria vaccine and preparation thereof

CN101636409AInactive Publication Date: 2010-01-27赫尔曼·比雅尔

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant malaria vaccine
  • Recombinant malaria vaccine
  • Recombinant malaria vaccine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Preparation of p83 / 30 fragment

[0041] The amino acid sequence of the p83 / 30 fragment is shown in SEQ ID NO: 1 (strain F) or SEQ ID NO: 2 (strain D). Cloning the nucleic acid sequence encoding the fragment into figure 1 In the expression vector pZE23D 83 / 30 shown in. The fragment-encoding nucleic acid is operably linked to the IPTG-inducible pA1lacO1 promoter. The Escherichia coli production strain is W3110Z2 (for example, Bacteriol. Ref. 36, (1972), 525-530; Proc. Natl. Acad. Sci. USA 78 (1981), 7069-7072).

[0042] E. coli cells were pre-cultured in LB medium. The preculture was diluted 1:50 with Superbroth and grown in fermentors at 37°C. In optical density (OD 600 ) is 1.5, add doxycycline (200ng / ml). in OD 600 = 4.5, IPTG (1 mM) was added.

[0043] 2.5h after induction with IPTG or at OD 600 At =7, the cells were collected.

[0044] The collected bacteria were disrupted by continuous homogenization at a turnover rate of 10 l / h and a maximum pressure of 1...

Embodiment 2

[0060] Preparation of p38 / 42 fragment

[0061] The amino acid sequence of the p38 / 42 fragment is shown in SEQ ID NO: 3 (strain F) or SEQ ID NO: 4 (strain D).

[0062] Inclusion bodies of the p38 / 42 fragment were prepared in substantially the same manner as described in Example 1 for the p83 / 30 fragment.

Embodiment 3

[0064] Preparation of compositions comprising equimolar amounts of p83 / 30 and p38 / 42 fragments

[0065] The inclusion bodies obtained in Examples 1 and 2 were respectively dissolved by adding a dissolution buffer (6M guanidine hydrochloride, 50 mM sodium phosphate, 10 mM dithiothreitol, 1 mM EDTA, pH 8.0) to the inclusion body (IB) .

[0066] For the p83 / 30 fragment, three different ratios of IB to lysis buffer were used, namely 1 g IB + 2.5 ml buffer, 1 g IB + 4.0 ml buffer and 1 g IB + 8.0 ml buffer. For the p38 / 40 fragment, 1 g of IB was added to 2.5 ml of buffer.

[0067] Filtrates were refolded by incubation overnight at room temperature in 500 mM arginine, 50 mM sodium phosphate, 1 mM reduced L-glutathione, 0.1 mM oxidized glutathione, 1 mM EDTA pH 8.0.

[0068] The resulting protein solution was concentrated 5-fold by ultrafiltration. The buffer was exchanged with 20 mM sodium phosphate, 50 mM NaCl, 0.01% Tween 80, pH 8.0. After filtration with a 0.2 μm filter, the ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention refers to a recombinant malaria vaccine and a method for its manufacture.

Description

technical field [0001] The invention relates to a recombinant malaria vaccine and a preparation method thereof. Background technique [0002] The merozoite surface protein (MSP-1) of the malaria parasite (Plasmodium) is present on the surface of the merozoite, which is the erythrocyte-invasive form of the parasite. MSP-1 is produced as a precursor protein with a molecular weight of about 190 kDa, which is proteolytically processed into four fragments called p83, p30, p38, and p42 during merozoite maturation. The form of non-covalent attachment is retained on the surface of the parasite. Upon invasion of red blood cells, further proteolytic cleavage occurs. [0003] The MSP-1 protein consists of several highly conserved regions, a dimorphic region, which is grouped with one of the two allelic forms in the N-terminal region and two relatively small minority developmental regions (oligomorphic block) related to (Tanabe et al., J.Mol.Biol.195 (1987) 273-287; Miller et al., Mo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
27 Jan 2010
Publication
CN101636409A
IPC
C07K14/445; A61K39/015
CPC
A61K39/015; C07K14/445; A61P33/06; A61P37/04; Y02A50/30
Inventors
赫尔曼·比雅尔; 罗尔夫·卢茨